These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

754 related items for PubMed ID: 26244756

  • 1. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
    Bradbury M, Founta C, Taylor W, Kucukmetin A, Naik R, Ang C.
    Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW, Huang WP, Liu TY, Ma K, Tao X, Zhu LR, Liao QP.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study.
    Twu NF, Ou YC, Liao CI, Chang WY, Yang LY, Tang YH, Chen TC, Chen CH, Chen TH, Yeh LS, Hsu ST, Chen YC, Chang CC, Cheng YM, Huang CY, Liu FS, Lin YS, Hsiao SM, Kan YY, Lai CH.
    Surg Oncol; 2016 Sep; 25(3):229-35. PubMed ID: 27566027
    [Abstract] [Full Text] [Related]

  • 7. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
    Guo L, Liu X, Wang L, Sun H, Huang K, Li X, Tang F, Li S, Yuan X, Wang C.
    Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T, Tanabe H, Nagata C, Suzuki J, Suzuki K, Takano H, Isonishi S, Ochiai K, Takakura S, Okamoto A.
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
    Tang Q, Tu YQ, Chen JH, Lyu XJ, Yan DD.
    Zhonghua Zhong Liu Za Zhi; 2018 Jun 23; 40(6):462-466. PubMed ID: 29936774
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
    Takekuma M, Kasamatsu Y, Kado N, Kuji S, Tanaka A, Takahashi N, Abe M, Hirashima Y.
    Int J Clin Oncol; 2016 Aug 23; 21(4):741-747. PubMed ID: 26857458
    [Abstract] [Full Text] [Related]

  • 12. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F, Sartori E, Maggino T, Zola P, Zanagnolo V, Cosio S, Ferrari F, Piovano E, Gadducci A.
    Gynecol Oncol; 2014 Mar 23; 132(3):611-7. PubMed ID: 24342439
    [Abstract] [Full Text] [Related]

  • 13. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL, Wu LY, Li N, Li XG, Huang MN, Zhang R.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun 23; 47(6):452-7. PubMed ID: 22932113
    [Abstract] [Full Text] [Related]

  • 14. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, Lee SP, Hong JH.
    Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):420-7. PubMed ID: 22365621
    [Abstract] [Full Text] [Related]

  • 15. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
    Mahmoud O, Hathout L, Shaaban SG, Elshaikh MA, Beriwal S, Small W.
    Gynecol Oncol; 2016 Dec 01; 143(3):539-544. PubMed ID: 27769525
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-IIB cervical cancer].
    Ma K, Yang YH, Yang X, Feng ZY, Liu TY, Wen HW, Liao QP.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec 18; 45(6):910-5. PubMed ID: 24343073
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
    Gadducci A, Landoni F, Cosio S, Zizioli V, Zola P, Ferrero AM, Lapresa MT, Maggino T, Sartori E.
    Anticancer Res; 2018 Jun 18; 38(6):3627-3634. PubMed ID: 29848719
    [Abstract] [Full Text] [Related]

  • 18. Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer?
    Lee DW, Lee KH, Lee JW, Park ST, Park JS, Lee HN.
    Int J Gynecol Cancer; 2013 Sep 18; 23(7):1303-10. PubMed ID: 23881101
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study.
    Ferrandina G, Palluzzi E, Gallotta V, Gambacorta MA, Autorino R, Turco LC, Macchia G, Cosentino F, Gui B, Mattoli MV, Ronzino G, Valentini V, Scambia G.
    Eur J Surg Oncol; 2018 Jul 18; 44(7):1062-1068. PubMed ID: 29753611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.